202172

Other LAPiS Study, a Phase I/II Study of iPS Cell-derived Cardiomyocyte Spheroids (HS-001) in Patients With HF is posted on ClinicalTrials.gov

2021611

Other Tatsuyoshi Hirano was appointed as Chief Administrative Officer

2021128

Other Taiji Edogawa was appointed as External Audit & Supervisory Board Member

2020915

Other Mutsuki Takano was appointed as Chief Financial Officer (CFO)

202062

Other Takehiko Kaneko was appointed as Chief Medical Officer (CMO)

2020130

Other Kay Deguchi was appointed as Independent Director

2019109

Other Akira Fujiyoshi was appointed as External Auditor

2019129

Other Kikuo Yasui was appointed as COO

2018930

Other Tomoyuki Kikugawa was appointed as External Auditor (full-time)